Accéder au contenu
Merck

Benzisothiazolones as modulators of macrophage migration inhibitory factor.

Bioorganic & medicinal chemistry letters (2011-07-02)
William L Jorgensen, Alexander Trofimov, Xin Du, Alissa A Hare, Lin Leng, Richard Bucala
RÉSUMÉ

Substituted N-phenylbenzisothiazolones have been investigated as inhibitors of the tautomerase activity of the proinflammatory cytokine MIF (macrophage migration inhibitory factor). Numerous compounds were found to possess antagonist activity in the low micromolar range with the most potent being the 6-hydroxy analog 1w. Compound 1w and the p-cyano analog 1c were also shown to exhibit significant inhibition of the binding of MIF to its transmembrane receptor CD74. Consistently, both compounds were also found to retard the MIF-dependent phosphorylation of ERK1/2 in human synovial fibroblasts.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1,2-Benzisothiazol-3(2H)-one, 97%
Supelco
1,2-Benzisothiazol-3(2H)-one, analytical standard